C8 Ceramide (d18:1.8:0)

A cell-permeable ceramide analog

此产品仅用于科学研究，我们不为任何个人用途提供产品和服务

库存: 现货

可选规格

包装

价格

促销价

数量
1mg

￥275.00

220.00

- +
5mg

￥1162.00

930.00

- +
10mg

￥1875.00

1500.00

- +
25mg

￥3900.00

3120.00

- +

已选 0 种 0 瓶

金额: ￥0.00

首页收藏

货号: ajci70452
CAS: 74713-59-0
别名: N-辛酰基-D-神经鞘氨醇; N-Octanoyl-D-erythro-sphingosine
分子式: C26H51NO3
分子量: 425.7
纯度: >98%
溶解度: 20mg/mL in DMSO, 22mg/mL in DMF, 33mg/mL in Ethanol
储存: Store at -20℃, stored under nitrogen
库存: 现货

Background

C8 Ceramide (d18:1.8:0) is a cell-permeable analog of naturally occurring ceramides. Unlike C2 ceramide, it is metabolized within cells to generate natural ceramides, often causing a dramatic increase in cellular ceramide levels. [1] For this reason, treatment of cells with C8 ceramide (d18:1.8:0) may more closely mimic the effects of ceramide elevation than does treatment with shorter chain ceramide analogs. C8 Ceramide (d18:1.8:0) likely mediates many diverse biological activities, as do natural ceramides. It promotes the differentiation of human keratinocytes [2]? and induces apoptosis of both human leukemia cells and the U937 cell line.[1] [3]?

Reference:
[1]. Karasavvas, N., Erukulla, R.K., Bittman, R., et al. Stereospecific induction of apoptosis in U937 cells by N-octanoyl-sphingosine stereoisomers and N-octyl-sphingosine. The ceramide amide group is not required for apoptosis. Eur. J. Biochem. 236(2), 729-737 (1996).
[2]. Wakita, H., Tokura, Y., Yagi, H., et al. Keratinocyte differentiation is induced by cell-permeant ceramides and its proliferation is promoted by sphingosine. Archives of Dermatological Research 286, 350-354 (1994).
[3]. Geley, S., Hartmann, B.L., and Kofler, R. Ceramides induce a form of apoptosis in human acute lymphoblastic leukemia cells that is inhibited by Bcl-2, but not by CrmA. FEBS Letters 400, 15-18 (1997).